계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Caprotec Bioanalytics
company
About
Caprotec Bioanalytics caters to the pharmaceutical, agrochemical, and biotech industries with a proprietary capture protein technology.
- 11 - 50
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $8.80M
- Industries
- Biotechnology,Health Care,Medical,Pharmaceutical
- Founded date
- Jan 1, 2006
- Number Of Employee
- 11 - 50
- Operating Status
- Active
caprotec bioanalytics has developed a ground-breaking, proprietary technology to reduce the complexity of protein mixtures and samples in a targeted and directed manner.caprotec's Capture Compound Mass Spectrometry (CCMS) Technology is based on multifunctional small molecules (Capture Compoundsâ„¢) that are used to target, capture, and isolate proteins based on their functionality. For many applications, CCMS is clearly superior to shotgun approaches - thus addressing an unmet need in the proteomics community.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$13.90M
Caprotec Bioanalytics has raised a total of
$13.90M
in funding over 2 rounds. Their latest funding was raised on
May 13, 2010 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 13, 2010 | Series B | $5.10M | 1 | — | — | Detail |
| Jan 10, 2008 | Series B | $8.80M | 1 |
ERP Startfonds
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Caprotec Bioanalytics is funded by 1 investors.
ERP Startfonds
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
ERP Startfonds
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
